We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
DAYVIGO (Eisai Australia Pty Ltd)
Product name
DAYVIGO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
224 (255 working days)
Active ingredients
lemborexant
Registration type
NCE/NBE
Indication
DAYVIGO (film coated tablet) is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance in accordance with latest DSM criteria.